News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
New genetic link to acute lymphoblastic leukaemia
A single letter change to DNA is linked to an increased risk of one of the most common forms of childhood leukaemia, a new study has revealed.
Fundraisers celebrated by Prime Minister with Points of Light Award after raising over £1m for our research
Prime Minister Theresa May has celebrated the devoted fundraising of Karen and Kevin Capel, who set up Christopher’s Smile in memory of their son who died of a brain tumour.
Hodgkin lymphoma survivors at high risk of second cancers
Patients who are cured of Hodgkin lymphoma are at a high risk of developing a second type of cancer, particularly if they have a family history of the disease, a major new study reports.
-and-actin-(green)-julia-sero-the-icr-2011.jpg?sfvrsn=14c02140_2 "Breast epithelial cells stained for DNA (magenta) and actin (green). Julia Sero / the ICR, 2011")
More breast cancer patients could benefit from promising new treatment, genetic study reveals
A greater number of breast cancers are genetically similar to rarer cases with faulty BRCA1 or BRCA2 genes, according to research from the Wellcome Trust Sanger Institute and The Institute of Cancer Research, London.
-content.tmb-hbmobile.jpg?Culture=en&sfvrsn=fec93f9d_2 "Dispensing medicines for a clinical trial (Jan Chlebik for the ICR, 2014) content")
Seize chance to close EU loophole in childhood cancer treatments, say cancer experts
Cancer treatments are not being trialled in children because of outdated European regulations which are in urgent need of reform, say cancer experts.
Our joint letter calling for reform of European regulations on clinical trials in children
Read the letter written in support of calls from The Institute of Cancer Research, London and its partner signatories to reform European regulations around trials of cancer treatments in children.
Protein ‘postcodes’ point to new targets for cancer treatment
Scientists have devised a new technique that establishes the ‘postcode’ for proteins within cancer cells, as a faster, more accurate way of identifying signals that are driving cancer growth.
ICR and Imperial College London launch the Cancer Research Centre of Excellence
The Institute of Cancer Research and Imperial College London have marked the start of a new joint partnership with the launch of the Cancer Research Centre of Excellence (CRCE) in London.
Good news as cancer patients will get access to more treatments after price drops
Pharmaceutical companies have lowered the prices of 14 key cancer medicines as part of a review by NICE of the old Cancer Drugs Fund (CDF).
Experimental drug could prevent cancer DNA repair to boost radiotherapy effects
Treating bladder and head-and-neck cancers with an experimental drug called CCT244747 makes radiotherapy more successful at killing them, scientists have discovered.
ICR partners in a new -180°C ‘cryo-EM’ machine
A new £3m grant from Wellcome to a consortium led by scientists at Imperial College London and The Institute of Cancer Research, London, will help to purchase a state-of-the-art cryo-electron microscopy machine.
Five stunning scientific images of our cancer research
Researchers at the ICR were challenged to capture in a single image their ground-breaking work making the discoveries that defeat cancer.
